Despite heterogeneity in study methods and design, some general patterns of preference clearly emerged. Overall, the results of this review suggest that treatment process has a quantifiable impact on preference and willingness to pay for treatment, even in many situations where safety and efficacy were the primary concerns. Patient preferences for treatment process attributes can inform drug development decisions to better meet the needs of patients and deliver improved outcomes.
No takes yet. Share an insight, caveat, or question.
Stewart et al. (2016) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: